These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24041892)

  • 1. Optimizing empiric antibiotic therapy in patients with severe β-lactam allergy.
    Koliscak LP; Johnson JW; Beardsley JR; Miller DP; Williamson JC; Luther VP; Ohl CA
    Antimicrob Agents Chemother; 2013 Dec; 57(12):5918-23. PubMed ID: 24041892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of an antibiotic cycling program on empirical therapy for gram-negative infections.
    Merz LR; Warren DK; Kollef MH; Fridkin SK; Fraser VJ
    Chest; 2006 Dec; 130(6):1672-8. PubMed ID: 17166981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral beta-lactam step down in bacteremic E. coli urinary tract infections.
    Saad S; Mina N; Lee C; Afra K
    BMC Infect Dis; 2020 Oct; 20(1):785. PubMed ID: 33087051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group.
    Averbuch D; Tridello G; Hoek J; Mikulska M; Akan H; Yanez San Segundo L; Pabst T; Özçelik T; Klyasova G; Donnini I; Wu D; Gülbas Z; Zuckerman T; Botelho de Sousa A; Beguin Y; Xhaard A; Bachy E; Ljungman P; de la Camara R; Rascon J; Ruiz Camps I; Vitek A; Patriarca F; Cudillo L; Vrhovac R; Shaw PJ; Wolfs T; O'Brien T; Avni B; Silling G; Al Sabty F; Graphakos S; Sankelo M; Sengeloev H; Pillai S; Matthes S; Melanthiou F; Iacobelli S; Styczynski J; Engelhard D; Cesaro S
    Clin Infect Dis; 2017 Nov; 65(11):1819-1828. PubMed ID: 29020364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral β-Lactam Antibiotics vs Fluoroquinolones or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Enterobacterales Bacteremia From a Urine Source.
    Sutton JD; Stevens VW; Chang NN; Khader K; Timbrook TT; Spivak ES
    JAMA Netw Open; 2020 Oct; 3(10):e2020166. PubMed ID: 33030555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empiric combination therapy for gram-negative bacteremia.
    Sick AC; Tschudin-Sutter S; Turnbull AE; Weissman SJ; Tamma PD
    Pediatrics; 2014 May; 133(5):e1148-55. PubMed ID: 24709936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study.
    Leibovici L; Paul M; Poznanski O; Drucker M; Samra Z; Konigsberger H; Pitlik SD
    Antimicrob Agents Chemother; 1997 May; 41(5):1127-33. PubMed ID: 9145881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decision-support models for empiric antibiotic selection in Gram-negative bloodstream infections.
    MacFadden DR; Coburn B; Shah N; Robicsek A; Savage R; Elligsen M; Daneman N
    Clin Microbiol Infect; 2019 Jan; 25(1):108.e1-108.e7. PubMed ID: 29705558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of Fluoroquinolone Resistance in Gram-Negative Bacteria Causing Bloodstream Infections.
    Dan S; Shah A; Justo JA; Bookstaver PB; Kohn J; Albrecht H; Al-Hasan MN
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2265-72. PubMed ID: 26833166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates--a multicentre, observational survey in critically ill patients.
    Vogelaers D; De Bels D; Forêt F; Cran S; Gilbert E; Schoonheydt K; Blot S;
    Int J Antimicrob Agents; 2010 Apr; 35(4):375-81. PubMed ID: 20122817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
    Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
    Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on the management of urinary tract infections in the era of antimicrobial resistance.
    Bader MS; Loeb M; Brooks AA
    Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consequences of avoiding β-lactams in patients with β-lactam allergies.
    Jeffres MN; Narayanan PP; Shuster JE; Schramm GE
    J Allergy Clin Immunol; 2016 Apr; 137(4):1148-1153. PubMed ID: 26688516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial.
    Bassetti M; Echols R; Matsunaga Y; Ariyasu M; Doi Y; Ferrer R; Lodise TP; Naas T; Niki Y; Paterson DL; Portsmouth S; Torre-Cisneros J; Toyoizumi K; Wunderink RG; Nagata TD
    Lancet Infect Dis; 2021 Feb; 21(2):226-240. PubMed ID: 33058795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-lactam and fluoroquinolone combination antibiotic therapy for bacteremia caused by gram-negative bacilli.
    Al-Hasan MN; Wilson JW; Lahr BD; Thomsen KM; Eckel-Passow JE; Vetter EA; Tleyjeh IM; Baddour LM
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1386-94. PubMed ID: 19164144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors for multidrug-resistant gram-negative bacteria among hospitalised patients with complicated urinary tract infections.
    Gomila A; Shaw E; Carratalà J; Leibovici L; Tebé C; Wiegand I; Vallejo-Torres L; Vigo JM; Morris S; Stoddart M; Grier S; Vank C; Cuperus N; Van den Heuvel L; Eliakim-Raz N; Vuong C; MacGowan A; Addy I; Pujol M;
    Antimicrob Resist Infect Control; 2018; 7():111. PubMed ID: 30220999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of prior receipt of antibiotics on the pathogen distribution and antibiotic resistance profile of key Gram-negative pathogens among patients with hospital-onset urinary tract infections.
    Bidell MR; Opraseuth MP; Yoon M; Mohr J; Lodise TP
    BMC Infect Dis; 2017 Feb; 17(1):176. PubMed ID: 28241755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection in cirrhosis: A prospective study.
    Bhattacharya C; Das-Mondal M; Gupta D; Sarkar AK; Kar-Purkayastha S; Konar A
    Ann Hepatol; 2019; 18(6):862-868. PubMed ID: 31635968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parenteral polymyxin B use in patients with multidrug-resistant gram-negative bacteremia and urinary tract infections: a retrospective case series.
    Pastewski AA; Caruso P; Parris AR; Dizon R; Kopec R; Sharma S; Mayer S; Ghitan M; Chapnick EK
    Ann Pharmacother; 2008 Sep; 42(9):1177-87. PubMed ID: 18664609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Decision Tree Using Patient Characteristics to Predict Resistance to Commonly Used Broad-Spectrum Antibiotics in Children With Gram-Negative Bloodstream Infections.
    Sick-Samuels AC; Goodman KE; Rapsinski G; Colantouni E; Milstone AM; Nowalk AJ; Tamma PD
    J Pediatric Infect Dis Soc; 2020 Apr; 9(2):142-149. PubMed ID: 30690525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.